(19)
(11) EP 1 562 987 A2

(12)

(88) Date of publication A3:
17.06.2004

(43) Date of publication:
17.08.2005 Bulletin 2005/33

(21) Application number: 03778300.8

(22) Date of filing: 05.11.2003
(51) International Patent Classification (IPC)7: C07K 14/705, C12N 15/86, C12N 5/06, A01K 67/027
(86) International application number:
PCT/EP2003/012325
(87) International publication number:
WO 2004/044003 (27.05.2004 Gazette 2004/22)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 11.11.2002 EP 02025161

(71) Applicant: Aventis Pharma Deutschland GmbH
65929 Frankfurt am Main (DE)

(72) Inventors:
  • KOSTENIS, Evi
    36323 Grebenau (DE)
  • WOHLFART, Paulus
    64625 Bensheim (DE)
  • HUBER, Jochen
    67133 Maxdorf (DE)
  • ROSPORT, Kai
    81372 München (DE)

   


(54) USE OF EDG2 RECEPTOR IN AN ANIMAL MODEL OF HEART FAILURE